| Richard M Viken, MD | |
|
2026 S Jackson St, Jacksonville, TX 75766-5822 | |
| (903) 586-5678 | |
| Not Available |
| Full Name | Richard M Viken |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 2026 S Jackson St, Jacksonville, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174508329 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | H3195 (Texas) | Primary |
| Entity Name | Christus Trinity Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285684225 PECOS PAC ID: 3072426741 Enrollment ID: O20031204001091 |
News Archive
Children fail at school, adults are unable to work and families are pushed into poverty as a result of uncorrected visual impairment.
New research will focus on finding better treatments for minority children with high-risk cancer malignancies - a group whose outcomes and survival rates are worse than other pediatric patients.
Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.
A new report from the Women's HIV Prevention Tracking Project (WHiPT), a collaborative initiative of AVAC and the ATHENA Network, features an unprecedented collection of voices from Kenya, Namibia, South Africa, Swaziland and Uganda reflecting on what male circumcision for HIV prevention means for women. It highlights women's perspectives, advocacy priorities and recommendations on this new prevention strategy.
› Verified 2 days ago
| Entity Name | Mother Frances Hospital Jacksonville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952306672 PECOS PAC ID: 5597751024 Enrollment ID: O20040421001092 |
News Archive
Children fail at school, adults are unable to work and families are pushed into poverty as a result of uncorrected visual impairment.
New research will focus on finding better treatments for minority children with high-risk cancer malignancies - a group whose outcomes and survival rates are worse than other pediatric patients.
Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.
A new report from the Women's HIV Prevention Tracking Project (WHiPT), a collaborative initiative of AVAC and the ATHENA Network, features an unprecedented collection of voices from Kenya, Namibia, South Africa, Swaziland and Uganda reflecting on what male circumcision for HIV prevention means for women. It highlights women's perspectives, advocacy priorities and recommendations on this new prevention strategy.
› Verified 2 days ago
| Entity Name | Sound Inpatient Physicians Of Texas I, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831424563 PECOS PAC ID: 8729133640 Enrollment ID: O20090828000300 |
News Archive
Children fail at school, adults are unable to work and families are pushed into poverty as a result of uncorrected visual impairment.
New research will focus on finding better treatments for minority children with high-risk cancer malignancies - a group whose outcomes and survival rates are worse than other pediatric patients.
Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.
A new report from the Women's HIV Prevention Tracking Project (WHiPT), a collaborative initiative of AVAC and the ATHENA Network, features an unprecedented collection of voices from Kenya, Namibia, South Africa, Swaziland and Uganda reflecting on what male circumcision for HIV prevention means for women. It highlights women's perspectives, advocacy priorities and recommendations on this new prevention strategy.
› Verified 2 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629307095 PECOS PAC ID: 3476688318 Enrollment ID: O20100317001021 |
News Archive
Children fail at school, adults are unable to work and families are pushed into poverty as a result of uncorrected visual impairment.
New research will focus on finding better treatments for minority children with high-risk cancer malignancies - a group whose outcomes and survival rates are worse than other pediatric patients.
Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.
A new report from the Women's HIV Prevention Tracking Project (WHiPT), a collaborative initiative of AVAC and the ATHENA Network, features an unprecedented collection of voices from Kenya, Namibia, South Africa, Swaziland and Uganda reflecting on what male circumcision for HIV prevention means for women. It highlights women's perspectives, advocacy priorities and recommendations on this new prevention strategy.
› Verified 2 days ago
| Entity Name | Hospitalist Medicine Physicians Of Texas - Tyler, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861037590 PECOS PAC ID: 4880021211 Enrollment ID: O20200225001897 |
News Archive
Children fail at school, adults are unable to work and families are pushed into poverty as a result of uncorrected visual impairment.
New research will focus on finding better treatments for minority children with high-risk cancer malignancies - a group whose outcomes and survival rates are worse than other pediatric patients.
Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.
A new report from the Women's HIV Prevention Tracking Project (WHiPT), a collaborative initiative of AVAC and the ATHENA Network, features an unprecedented collection of voices from Kenya, Namibia, South Africa, Swaziland and Uganda reflecting on what male circumcision for HIV prevention means for women. It highlights women's perspectives, advocacy priorities and recommendations on this new prevention strategy.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard M Viken, MD 2026 S Jackson St, Jacksonville, TX 75766-5822 Ph: (903) 586-5678 | Richard M Viken, MD 2026 S Jackson St, Jacksonville, TX 75766-5822 Ph: (903) 586-5678 |
News Archive
Children fail at school, adults are unable to work and families are pushed into poverty as a result of uncorrected visual impairment.
New research will focus on finding better treatments for minority children with high-risk cancer malignancies - a group whose outcomes and survival rates are worse than other pediatric patients.
Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.
A new report from the Women's HIV Prevention Tracking Project (WHiPT), a collaborative initiative of AVAC and the ATHENA Network, features an unprecedented collection of voices from Kenya, Namibia, South Africa, Swaziland and Uganda reflecting on what male circumcision for HIV prevention means for women. It highlights women's perspectives, advocacy priorities and recommendations on this new prevention strategy.
› Verified 2 days ago
Dr. Kenya Sekoni Etim, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 203 Nacogdoches St Ste 280, Jacksonville, TX 75766 Phone: 903-541-5396 | |
Dr. Matthew Todd Proctor, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2026 S Jackson St, Jacksonville, TX 75766 Phone: 903-586-5678 | |
Craig C Weaver, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2026 S Jackson, Jacksonville, TX 75766 Phone: 903-586-5678 | |
William Milawski, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2026 S Jackson St, Jacksonville, TX 75766 Phone: 903-586-5678 | |
Dr. Ryan Dean Ford, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2026 S Jackson St, Jacksonville, TX 75766 Phone: 903-541-4599 | |
Dr. Alison Collins, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2026 S Jackson St, Jacksonville, TX 75766 Phone: 903-586-5678 |